|
|
Volumn 13, Issue 7, 2016, Pages 369-
|
|
Prostate cancer: Genetics of mCRPC tracked in ctDNA
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN RECEPTOR;
CIRCULATING TUMOR DNA;
DNA;
ENZALUTAMIDE;
MYC PROTEIN;
RETINOBLASTOMA PROTEIN;
SCATTER FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
CANCER CHEMOTHERAPY;
CANCER GENETICS;
CANCER RESISTANCE;
CANCER SURVIVAL;
CASTRATION RESISTANT PROSTATE CANCER;
COMPARATIVE GENOMIC HYBRIDIZATION;
DNA DETERMINATION;
DNA MICROARRAY;
DNA SEQUENCE;
GENE AMPLIFICATION;
GENE DOSAGE;
GENE MUTATION;
HIGH RISK PATIENT;
HUMAN;
METASTATIC CASTRATION RESISTANT PROSTATE CANCER;
NOTE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
PROSTATE BIOPSY;
SURVIVAL TIME;
MALE;
CIRCULATING TUMOR DNA;
HUMANS;
MALE;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
|
|
EID: 84970027825
PISSN: 17594812
EISSN: 17594820
Source Type: Journal
DOI: 10.1038/nrurol.2016.98 Document Type: Note |
|
Times cited : (1)
|
|
References (1)
|
